Condom Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Condom Market is projected to expand from USD 12.22 Billion in 2025 to USD 20.31 Billion by 2031, reflecting an 8.84% CAGR. A condom is defined as a sheath-shaped barrier device, usually made of latex or polyurethane, used during sexual intercourse to decrease the likelihood of unintended pregnancy and prevent infection transmission. The market is chiefly sustained by core drivers such as the rising incidence of sexually transmitted diseases and strict government family planning initiatives. These factors establish a lasting structural demand for affordable prophylactic solutions that operates independently of temporary consumer trends, ensuring a fundamental need for disease prevention products within international healthcare systems.

However, the industry confronts a major challenge concerning the decrease in international funding and procurement, which obstructs broad distribution in key regions. Data from the Joint United Nations Programme on HIV/AIDS reveals that in 2025, estimated global public sector condom procurement dropped by an average of 30 percent from the peaks seen in 2011. This contraction in subsidized availability acts as a significant barrier to market volume growth, particularly in developing economies that rely heavily on donor-funded sexual health programs for a steady supply.

Market Drivers

The growing global prevalence of sexually transmitted infections (STIs) and HIV acts as a primary catalyst for the condom market, requiring consistent manufacturing output to satisfy public health needs. As infection rates rise, health agencies prioritize barrier methods as a first line of defense, securing steady market volume irrespective of commercial cycles. According to the 'Results Report 2025' by The Global Fund to Fight AIDS, Tuberculosis and Malaria published in September 2025, 1.3 million new HIV infections were recorded globally in 2024, highlighting the crucial need for continued prophylactic access. This trend is also evident in developed nations; HIV.gov reported that provisional surveillance data in 2025 showed over 2.2 million cases of chlamydia, gonorrhea, and syphilis in the United States in 2024, reinforcing the structural necessity to curb these transmission vectors through widespread availability.

Government-led initiatives for family planning and disease prevention serve as a second major driver, stabilizing demand through extensive institutional procurement programs. National health departments and international bodies actively subsidize or freely distribute prophylactics to high-risk groups, creating a reliable volume channel for manufacturers that balances volatility in the private retail sector.

These programs are particularly aggressive in regions with high disease burdens, where state intervention results in massive unit consumption. For instance, the Uganda AIDS Commission's 'Uganda Scores 97% HIV Suppression' report from December 2025 noted that public sector distribution of male condoms rose to approximately 207.9 million units in 2024. Such broad public sector commitments ensure that despite funding changes, core industrial output remains engaged to fulfill these mandated supply chains.

Market Challenges

The decline in international funding and procurement poses a critical barrier to the expansion of the Global Condom Market. This financial contraction directly affects the volume of products distributed in developing regions, where market growth depends heavily on subsidized bulk purchasing by global health entities. When donor contributions stagnate or fall, the supply chain fractures, causing immediate stock shortages in high-demand areas that lack the economic ability to shift to commercial retail purchasing. Consequently, manufacturers face unpredictable order volumes, which disrupts production planning and undermines revenue stability.

This reliance on external aid creates a fragile market ecosystem prone to budgetary deficits. The failure to secure consistent financing limits the reach of prevention programs, effectively capping market volume. According to the Global Fund, in 2024, decreasing international funding presented a serious threat to disease prevention progress, contributing to a scenario where 1.3 million new HIV infections were recorded globally. This correlation highlights how funding gaps directly lead to reduced product accessibility and market stagnation, preventing the industry from realizing its full potential in emerging economies.

Market Trends

The diversification of pleasure-enhancing textures and formulations is fundamentally reshaping the market by shifting consumer focus from basic prophylactic utility to sexual wellness and experiential satisfaction. Manufacturers are increasingly engineering products with stimulating ribs, dots, and desensitizing lubricants to attract a premium clientele that operates outside the price-sensitive public sector. This strategy effectively insulates brands from commodity pricing pressures by marketing condoms as lifestyle products rather than medical necessities. According to Reckitt Benckiser Group PLC's 'Q3 2025 Trading Update' from October 2025, the company recorded double-digit growth in its Intimate Wellness category within emerging markets, specifically driven by the rapid uptake of new performance-focused innovations such as Benzocaine-infused condoms.

Simultaneously, there is a distinct shift toward direct-to-consumer and subscription-based retail models which circumvents the volatility associated with international donor funding. While institutional procurement faces budgetary constraints, the private retail segment is expanding as brands establish direct relationships with users through e-commerce and physical retail partnerships that emphasize brand loyalty and consistent availability. This commercial robustness provides a counterweight to the declining government tender volumes, ensuring revenue stability through recurring private purchases. According to Church & Dwight Co., Inc.'s 'Q3 2025 Earnings Press Release' from October 2025, the company's domestic organic sales grew by 2.3 percent, a performance primarily led by the sustained retail demand for its premium Trojan condom portfolio.

Key Players Profiled in the Condom Market

• Okamoto Industries, Inc.
• Cupid Limited
• Reckitt Benckiser Group
• Karex Berhad
• Church & Dwight Co., Inc.
• Fuji Latex Co., Ltd.
• Leloi AB
• LifeStyles Healthcare Pte Ltd.
• Veru, Inc.
• Mayer Laboratories, Inc.

Report Scope

In this report, the Global Condom Market has been segmented into the following categories:

Condom Market, by Gender:

• Male
• Female

Condom Market, by Type:

• Latex Condom
• Non-Latex Condom

Condom Market, by Distribution Channel:

• Supermarkets/Hypermarkets
• Drug/Pharmacy Stores
• Convenience Stores
• Online
• Others (Departmental Stores
• etc.)

Condom Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Condom Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.